| | Research Articles Patients with High-Grade Gliomas Harboring Deletions of Chromosomes 9p and 10q Benefit from Temozolomide Treatment Silke Wemmert, Ralf Ketter, Jörg Rahnenführer, Niko Beerenwinkel, Martin Strowitzki, Wolfgang Feiden, Christian Hartmann, Thomas Lengauer, Florian Stockhammer, Klaus D Zang, Eckart Meese, Wolf-Ingo Steudel, Andreas von Deimling, and Steffi Urbschat PMCID: PMC1502025 A3 Adenosine Receptors Modulate Hypoxia-Inducible Factor-1α Expression in Human A375 Melanoma Cells Stefania Merighi, Annalisa Benini, Prisco Mirandola, Stefania Gessi, Katia Varani, Edward Leung, Stephen MacLennan, Pier Giovanni Baraldi, and Pier Andrea Borea PMCID: PMC1502026 The Vascular-Targeting Fusion Toxin VEGF121/rGel Inhibits the Growth of Orthotopic Human Bladder Carcinoma Tumors Khalid A Mohamedali, Daniel Kedar, Paul Sweeney, Ashish Kamat, Darren W Davis, Beryl Y Eve, Samuel Huang, Philip E Thorpe, Colin P Dinney, and Michael G Rosenblum PMCID: PMC1550288 Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells Ravi D Rao, Ann C Mladek, Jeffrey D Lamont, Jennie M Goble, Charles Erlichman, C David James, and Jann N Sarkaria PMCID: PMC1502028 Gastrin Exerts Pleiotropic Effects on Human Melanoma Cell Biology Véronique Mathieu, Tatjana Mijatovic, Marc van Damme, and Robert Kiss PMCID: PMC1502029 Sequential Molecular and Cellular Events during Neoplastic Progression: A Mouse Syngeneic Ovarian Cancer Model Paul C Roberts, Emilio P Mottillo, Andrea C Baxa, Henry H Q Heng, Nicole Doyon-Reale, Lucie Gregoire, Wayne D Lancaster, Raja Rabah, and Eva M Schmelz PMCID: PMC1502030 Vascular Targeting in Pancreatic Cancer: The Novel Tubulin-Binding Agent ZD6126 Reveals Antitumor Activity in Primary and Metastatic Tumor Models Axel Kleespies, Gudrun Köhl, Michael Friedrich, Anderson J Ryan, Alan Barge, Karl-Walter Jauch, and Christiane J Bruns PMCID: PMC1502031 |
